Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Annals of Internal Medicine

• Publication date

  2016-02-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/M15-1536PMID 26756606PMCID PMC5079106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening for breast cancer with mammography

  2024cited by this paper
• Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening

  2018cited by this paper
• Digital Breast Tomosynthesis and the Challenges of Implementing an Emerging Breast Cancer Screening Technology Into Clinical Practice.

  2016cited by this paper
• Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.

  2015cited by this paper
• Public Opinions about Overdiagnosis: A National Community Survey

  2015cited by this paper
• Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts

  2015cited by this paper
• The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age–Period–Cohort Model

  2015cited by this paper
• Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.

  2015cited by this paper
• Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

  2015cited by this paper
• Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review.

  2015cited by this paper
• Identifying women with dense breasts at high risk for interval cancer: a cohort study.

  2015cited by this paper
• The effects of population‐based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy

  2015cited by this paper
• Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.

  2015cited by this paper
• Breast-cancer screening--viewpoint of the IARC Working Group.

  2015cited by this paper
• Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods

  2015cited by this paper
• Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures.

  2015cited by this paper
• Abolishing mammography screening programs? A view from the Swiss Medical Board.

  2014cited by this paper
• Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.

  2014cited by this paper
• Breast-specific gamma imaging: correlations with mammographic and clinicopathologic characteristics of breast cancer.

  2014cited by this paper
• Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial

  2014cited by this paper
• A reality check for overdiagnosis estimates associated with breast cancer screening.

  2014cited by this paper
• Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

  2014cited by this paper
• Breast-specific gamma imaging for the detection of breast cancer in dense versus nondense breasts.

  2014cited by this paper
• Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case–control studies

  2014cited by this paper
• The Value of Modern Mammography Screening in the Control of Breast Cancer: Understanding the Underpinnings of the Current Debates

  2014cited by this paper
• Quantifying the benefits and harms of screening mammography.

  2014cited by this paper
• The harms and benefits of modern screening mammography

  2014cited by this paper
• Prevalence of mammographically dense breasts in the United States.

  2014cited by this paper
• European Breast Cancer Service Screening Outcomes: A First Balance Sheet of the Benefits and Harms

  2014cited by this paper
• Breast cancer screening using tomosynthesis in combination with digital mammography.

  2014cited by this paper
• Genetic susceptibility to triple-negative breast cancer.

  2013cited by this paper
• Benign breast disease, mammographic breast density, and the risk of breast cancer.

  2013cited by this paper
• Screening for breast cancer with mammography.

  2013cited by this paper
• Digital breast tomosynthesis and the challenges of implementing an emerging breast cancer screening technology into clinical practice.

  2013cited by this paper
• Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients.

  2013cited by this paper
• Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening Strategies

  2013cited by this paper
• Genome-wide association studies identify four ER negative–specific breast cancer risk loci

  2013cited by this paper
• Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.

  2013cited by this paper
• Short-Term Outcomes of Screening Mammography Using Computer-Aided Detection

  2013cited by this paper
• Impact of Mammography Screening Interval on Breast Cancer Diagnosis by Menopausal Status and BMI

  2013cited by this paper
• Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?

  2013cited by this paper
• Influence of Study Features and Methods on Overdiagnosis Estimates in Breast and Prostate Cancer Screening

  2013cited by this paper
• Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

  2012cited by this paper
• Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years

  2012cited by this paper
• Risk Factors for Breast Cancer for Women Aged 40 to 49 Years

  2012cited by this paper
• Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality

  2012cited by this paper
• The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Observational Studies

  2012cited by this paper
• Cancer screening in the United States, 2012

  2012cited by this paper
• Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness

  2011cited by this paper
• External Validation of an Index to Predict Up to 9‐Year Mortality of Community‐Dwelling Adults Aged 65 and Older

  2011cited by this paper
• Comparative Effectiveness of Digital Versus Film-Screen Mammography in Community Practice in the United States

  2011cited by this paper
• Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms (Annals of Internal Medicine (2009) 151, (738-747))

  2010influential reference
• Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

  2009cited by this paper
• Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.

  2009cited by this paper
• Obesity, mammography use and accuracy, and advanced breast cancer risk.

  2008cited by this paper
• Mammographic density and the risk and detection of breast cancer.

  2007cited by this paper
• Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.

  2006cited by this paper
• The MISCAN-Fadia continuous tumor growth model for breast cancer.

  2006cited by this paper
• Effect of screening and adjuvant therapy on mortality from breast cancer.

  2006cited by this paper
• The Wisconsin Breast Cancer Epidemiology Simulation Model.

  2006cited by this paper
• A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends.

  2006cited by this paper
• Prospective breast cancer risk prediction model for women undergoing screening mammography.

  2006cited by this paper
• Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model

  2006cited by this paper
• Changing patterns in breast cancer incidence trends.

  2006cited by this paper
• The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.

  2006cited by this paper
• Performance benchmarks for screening mammography.

  2006cited by this paper
• Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.

  2006cited by this paper
• Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for 7 Health-Related Quality-of-Life Scores

  2006cited by this paper
• A stochastic model for predicting the mortality of breast cancer.

  2006cited by this paper
• A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.

  2006cited by this paper
• Retrospective cost-effectiveness analysis of screening mammography.

  2006cited by this paper
• The relationship between condom use and herpes simplex virus acquisition

  2005cited by this paper
• Effect of screening and adjuvant therapy on mortality from breast cancer

  2005cited by this paper
• Long-term effects of mammography screening: updated overview of the Swedish randomised trials.

  2002cited by this paper
• Cancer screening in elderly patients: a framework for individualized decision making.

  2001cited by this paper
• The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up.

  2000cited by this paper
• Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine.

  1997cited by this paper
• Assessing the effectiveness of health interventions for cost-effectiveness analysis

  1997cited by this paper
• Effect of age, breast density, and family history on the sensitivity of first screening mammography.

  1996cited by this paper
• The impact of a breast cancer screening programme on quality‐adjusted life‐years

  1991cited by this paper
• Appendix S 1 A The probabilistic model

  year unknowncited by this paper
• Clinical Guidelines Annals of Internal Medicine Effects of Mammography Screening Under Different Screening

  year unknowncited by this paper

• Five-Year Absolute Risk–Based and Age-Based Breast Cancer Screening in the US

  2026cites this paper
• Screening Outcomes of Supplemental Automated Breast Ultrasound in Women With Nondense Breasts Undergoing Mammography

  2026cites this paper
• Modeling Early-Onset Cancer Kinetics Reveals Changes in Underlying Risk and the Impact of Population Screening.

  2025cites this paper
• Mammography screening and risk factor prevalence by sexual identity: A comparison of two national surveys

  2025cites this paper
• Characteristics of Participants and Findings of the National Breast Cancer Early Detection Program in Saudi Arabia

  2025influential citation
• Overdiagnosis of ductal carcinoma in situ by grade and definition in population-based screening: A modeling study

  2025cites this paper
• Mathematical Modeling to Address Questions in Breast Cancer Screening: An Overview of the Breast Cancer Models of the Cancer Intervention and Surveillance Modeling Network.

  2025cites this paper
• Exploring Bayesian adaptive designs in multi-arm randomized controlled trials with a patient preference arm.

  2025cites this paper
• Evaluating breast cancer screening consortium and MammoRisk plus polygenic risk score 313 for breast cancer risk prediction in UK Biobank.

  2025cites this paper
• Impact of endocrine therapy regimens for early-stage ER+/HER2- breast cancer on contralateral breast cancer risk

  2025cites this paper
• Plausibility of V-doped aluminium nitride nanotubes for breast cancer detection: A DFT investigation

  2025cites this paper
• A stochastic model for evaluating the progression of ductal carcinoma in situ breast cancer using Norwegian breast cancer screening program data

  2025cites this paper
• Assessment of the impact of multi-cancer early detection test screening intervals on late-stage cancer at diagnosis and mortality using a state-transition model

  2025cites this paper
• Persistent Effect of Redlining on Survival from Screenable Cancers in Washington State, 2000–2018

  2025cites this paper
• A Systematic Review of the Cost-Effectiveness of Screening Modalities for Breast Cancer in European Countries

  2025cites this paper
• The Optimal Age of Helicobacter pylori Screen‐and‐Treat for Gastric Cancer Prevention in the United States

  2025cites this paper
• Invitation strategies for improving uptake in cervical, breast, and colorectal cancer screening: a systematic review.

  2025cites this paper
• Life Expectancy Predicted by Decision-Analytic Models Evaluating Screening for Prostate, Lung, Breast, and Colorectal Cancer: A Systematic Review Focusing on Competing Mortality Risks

  2025cites this paper
• A Scoping Review on Calibration Methods for Cancer Simulation Models

  2025cites this paper
• Weighing the Benefits and Risks of Mammography Screening Strategies.

  2024cites this paper
• Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density.

  2024cites this paper
• A Semiautonomous Deep Learning System to Reduce False Positives in Screening Mammography

  2024cites this paper
• USPSTF Recommendations and Overdiagnosis.

  2024cites this paper
• Prevalence of Imaging Detected Silent Female Breast Cancer in Autopsy Specimens: Study of the Disease Held by Image-Guided Biopsies

  2024cites this paper
• Role of life satisfaction, emotional support, and feeling of social isolation on adherence to breast cancer screening recommendations among US women.

  2024cites this paper
• Feasibility of Prospective Assignment of Initial Method of Detection (MOD) of Breast Cancer: A Multi-Center Pilot Study.

  2024cites this paper
• Increasing inclusion and equity for Black women in breast cancer clinical trials.

  2024cites this paper
• Screening Mammography for 40-Year-Old Women-Whose Decision?

  2024cites this paper
• Modeling early-onset cancer kinetics to study changes in underlying risk, detection, and impact of population screening

  2024cites this paper
• Evaluating the Use of ChatGPT to Accurately Simplify Patient-centered Information about Breast Cancer Prevention and Screening.

  2024cites this paper
• Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention.

  2024cites this paper
• Population Screening for Breast Cancer

  2024cites this paper
• Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness Evaluation

  2024cites this paper
• Screening for Breast Cancer: A Comparative Review of Guidelines

  2024cites this paper
• Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort

  2024cites this paper
• Carney complex predisposes to breast cancer: prospective study of 50 women.

  2024cites this paper
• Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.

  2024cites this paper
• Development and validation of a model and nomogram for breast cancer diagnosis based on quantitative analysis of serum disease-specific haptoglobin N-glycosylation

  2024cites this paper
• A Systematic Review to Evaluate the Barriers to Breast Cancer Screening in Women with Disability

  2024cites this paper
• Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.

  2024cites this paper
• Potentiality of phosphide-based nanotubes for breast cancer detection: A DFT investigation

  2024cites this paper
• Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and Surveillance Modeling Network Estimates.

  2024cites this paper
• New Recommendations for Breast Cancer Screening-In Pursuit of Health Equity.

  2024cites this paper
• Mammography Screening Should Begin at Age 40 Years.

  2024cites this paper
• Breast cancer mammographic screening by different guidelines among women of different races/ethnicities

  2023cites this paper
• Prolonged screening interval due to the COVID-19 pandemic and its association with tumor characteristics and treatment; a register-based study from BreastScreen Norway.

  2023cites this paper
• Screening Mammography Utilization in the United States.

  2023cites this paper
• Benefits and Harms of Mammography Screening in 75 + Women to Inform Shared Decision-making: a Simulation Modeling Study

  2023cites this paper
• Breast cancer screening and diagnosis in older adults women in Brazil: why it is time to reconsider the recommendations

  2023cites this paper
• Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047.

  2023cites this paper
• Revisiting the Standard Blueprint for Biomarker Development to Address Emerging Cancer Early Detection Technologies.

  2023cites this paper
• Putting Evidence Into Practice: An Update on the US Preventive Services Task Force Methods for Developing Recommendations for Preventive Services

  2023cites this paper
• Risk of cancer versus risk of cancer diagnosis? Accounting for diagnostic bias in predictions of breast cancer risk by race and ethnicity

  2023cites this paper
• Travel Burden to Cancer Screening and Treatment Facilities Among Washington Women: Data From an Integrated Healthcare Delivery System

  2023cites this paper
• Breast Cancer: Risk Assessment, Screening, and Primary Prevention.

  2023cites this paper
• Factors Associated With False-Positive Recalls in Mammography Screening.

  2023cites this paper
• Optimal Genetic Testing of Families

  2023cites this paper
• Patients Will Benefit if We Expand Cancer Registries to Capture Method of Detection.

  2023cites this paper
• Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency

  2023cites this paper
• Patient counseling for breast cancer screening: Taking changes to USPSTF recommendations into account.

  2023influential citation
• Breast Cancer Screening and Prevention

  2023cites this paper
• The Association Between Mammography Screening Frequency and Breast Cancer Treatment and Outcomes: A Retrospective Cohort Study.

  2023cites this paper
• Expanding Cancer Registries to Capture Method of Detection.

  2023cites this paper
• Fusion Model for Classification Performance Optimization in a Highly Imbalance Breast Cancer Dataset

  2023cites this paper
• Opportunities, challenges, and future directions for simulation modeling the effects of structural racism on cancer mortality in the United States: a scoping review.

  2023cites this paper
• A health equity framework to support the next generation of cancer population simulation models.

  2023cites this paper
• Data gaps and opportunities for modeling cancer health equity.

  2023cites this paper
• Understanding Risk Who is at risk for developing breast cancer?

  2022cites this paper
• Designing optimal allocations for cancer screening using queuing network models

  2022cites this paper
• À l’encontre du statu quo en matière de dépistage

  2022cites this paper
• A deep learning algorithm for reducing false positives in screening mammography

  2022cites this paper
• Mammography Stages Adoption and Health Beliefs in Mexican Women

  2022cites this paper
• Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial

  2022cites this paper
• Going against the status quo in screening

  2022cites this paper
• Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model.

  2022cites this paper
• VinDr-Mammo: A large-scale benchmark dataset for computer-aided diagnosis in full-field digital mammography

  2022cites this paper
• Clinical Decision Support with or without Shared Decision Making to Improve Preventive Cancer Care: A Cluster-Randomized Trial

  2022cites this paper
• Update on the clinical management of multiple endocrine neoplasia type 1

  2022cites this paper
• Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography

  2022cites this paper
• A Procedure for Eliciting Women’s Preferences for Breast Cancer Screening Frequency

  2022cites this paper
• Breast Density Knowledge in a Screening Mammography Population Exposed to Density Notification.

  2022cites this paper
• Optimal breast cancer risk reduction policies tailored to personal risk level

  2022cites this paper
• Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.

  2022cites this paper
• A multi-objective constrained partially observable Markov decision process model for breast cancer screening

  2022cites this paper
• A Comparison of Techniques for Class Imbalance in Deep Learning Classification of Breast Cancer

  2022cites this paper
• Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer

  2022cites this paper
• Impact of psychosocial, behavioral and lifestyle factors on subjective cognitive complaints and perceived quality of life in a large cohort of Italian breast cancer patients

  2022cites this paper
• Prevalence of Imaging-Detected Silent Female Breast Cancer in Autopsy Specimens: A Study Using Image-Guided Biopsies

  2022cites this paper
• Sequentially calibrating a Bayesian microsimulation model to incorporate new information and assumptions

  2022cites this paper
• Breast Cancer Screening in Women With Dense Breasts: Current Status and Future Directions for Appropriate Risk Stratification and Imaging Utilization.

  2022cites this paper
• Breast Cancer Risk and Screening Mammography Frequency Among Multiethnic Women.

  2022cites this paper
• Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis

  2022cites this paper
• Cancer systems epidemiology: Overcoming misconceptions and integrating systems approaches into cancer research

  2022cites this paper
• The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs

  2022cites this paper
• A multi-objective constrained POMDP model for breast cancer screening

  2022cites this paper
• Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population.

  2022cites this paper
• Health Economics Research in Cancer Screening: Research Opportunities, Challenges, and Future Directions.

  2022cites this paper
• Personalized Disease Prevention (PDP): study protocol for a cluster-randomized clinical trial

  2022cites this paper
• Harms and Benefits of Cancer Screening.

  2021cites this paper
• Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the USPSTF

  2021cites this paper